Literature DB >> 12646507

Fecal bile acid concentrations in a subpopulation of the wheat bran fiber colon polyp trial.

David S Alberts1, Janine G Einspahr, David L Earnest, Mary F Krutzsch, Po Lin, Lisa M Hess, David K Heddens, Denise J Roe, Maria Elena Martínez, Gerald Salen, A K Batta.   

Abstract

Factors that affect the concentration of secondary bile acids in the aqueous phase of stool may have a greater impact on colon carcinogenesis than those that only modify the total fecal bile acid concentration. This hypothesis was tested using stool samples of a subset of participants enrolled in a Phase III colorectal adenomatous polyp prevention trial, which documented the inability of a 13.5 g/day wheat bran fiber (WBF) supplement to reduce polyp recurrence. Stool was collected from 68 consecutively consented participants who were enrolled in a Phase III clinical trial of WBF for the prevention of adenomatous polyp recurrence. Nineteen (27.9%) of these fecal bile acid substudy participants were on the low fiber (2.0 g/day) intervention group, whereas 49 (72.7%) were on the high fiber (13.5 g/day) intervention group for approximately 3 years. Sixty-four participants had both the aqueous and solid phases of stool samples analyzed for bile acid content. Bile acid concentrations, measured in microg/ml for fecal water and microg/mg for dry feces, were determined for lithochilic, deoxycholic, chenodeoxycholic, cholic, ursodeoxycholic, isodeoxycholic, isoursodeoxycholic, ursocholic, 7-ketolithocholic, and 12-ketolithocholic acids. There were no significant differences between the low and high fiber groups concerning mean or median aqueous phase concentrations of lithocholic or deoxycholic bile acids. In contrast, the median concentrations of deoxycholic acid and other secondary bile acids (including lithochilic, isodeoxycholic, ursodeoxycholic, isoursodeoxycholic, ursocholic, 7-ketolithocholic, and 12-ketolithocholic acids) were significantly lower for the high fiber group in the solid-phase stool (P < 0.05). These results document that a high WBF intervention, taken for a median of 2.4 years, does not significantly reduce aqueous-phase concentrations of secondary bile acids in stool, although their concentrations in solid-phase stool were suppressed. Thus, the inability of the high WBF intervention to reduce colorectal adenoma recurrence may be a consequence of its lack of effect on fecal aqueous-phase secondary bile acid concentrations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646507

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

Review 1.  Impact of Dietary Fibers on Nutrient Management and Detoxification Organs: Gut, Liver, and Kidneys.

Authors:  Dorothy A Kieffer; Roy J Martin; Sean H Adams
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

2.  Physical activity as a determinant of fecal bile acid levels.

Authors:  Betsy C Wertheim; María Elena Martínez; Erin L Ashbeck; Denise J Roe; Elizabeth T Jacobs; David S Alberts; Patricia A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

3.  Deoxycholic Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Exacerbates DSS-Induced Colitis through Promoting Cathepsin B Release.

Authors:  Shengnan Zhao; Zizhen Gong; Xixi Du; Chunyan Tian; Lingyu Wang; Jiefei Zhou; Congfeng Xu; Yingwei Chen; Wei Cai; Jin Wu
Journal:  J Immunol Res       Date:  2018-05-09       Impact factor: 4.818

4.  Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development.

Authors:  Talima Pearson; J Gregory Caporaso; Monica Yellowhair; Nicholas A Bokulich; Megha Padi; Denise J Roe; Betsy C Wertheim; Mark Linhart; Jessica A Martinez; Cherae Bilagody; Heidie Hornstra; David S Alberts; Peter Lance; Patricia A Thompson
Journal:  Cancer Med       Date:  2019-01-16       Impact factor: 4.452

5.  Deoxycholic Acid Triggers NLRP3 Inflammasome Activation and Aggravates DSS-Induced Colitis in Mice.

Authors:  Shengnan Zhao; Zizhen Gong; Jiefei Zhou; Chunyan Tian; Yanhong Gao; Congfeng Xu; Yingwei Chen; Wei Cai; Jin Wu
Journal:  Front Immunol       Date:  2016-11-28       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.